Healthcare Leaders Income ETF

Healthcare Leaders Income ETF

Healthcare Leaders ETF
Date Symbol NAV ($) NAV Change ($) MKT ($) MKT Change ($) Distribution Total ($)

Fund Quick Facts October 31, 2017

TSX Code HHL |  HHL.U
Cusip HHL 42227H101
Cusip HHL.U 42227H200
Net AUM $252.7 million
Management Fee 0.85%
Total Holdings 23
Income Distribution Monthly
Recent Distribution $0.0583
Distribution Method Cash or DRIP
Eligible RRSP/RRIF/RESP/TFSA

Portfolio Analysis* October 31, 2017

Average Market Capitalization (USD) $113.3B
Number of Equity Securities 20
Average Dividend Yield 2.15%
Average P/E 16.22
5 Year Average Return on Equity 30.88%

Top Ten Holdings

October 31, 2017

Security Portfolio (%)
Anthem, Inc. 5.6
Stryker Corporation 5.3
AstraZeneca PLC ADR 5.3
UnitedHealth Group Inc. 5.2
Bristol-Myers Squibb Company 5.1
Johnson & Johnson 5.0
Pfizer Inc. 5.0
Quest Diagnostics Inc. 5.0
Medtronic PLC 4.9
Novartis AG ADR 4.8

Fund Overview

The Fund invests in an equally-weighted portfolio of equity securities of 20 Healthcare Issuers from the Healthcare Leaders Investable Universe that have a minimum market capitalization of US$5 billion at the time of investment and have options in respect of their Equity Securities listed on a recognized options exchange. The portfolio is rebalanced semi-annually back to equal weights.

The Fund’s investment objectives are to provide Unitholders with: (i) the opportunity for capital appreciation; (ii) monthly cash distributions; and (iii) lower overall volatility of Portfolio returns than would otherwise be experienced by owning Equity Securities of the Healthcare Leaders directly.

In order to seek to generate additional returns, the Investment Manager will sell call options each month on Equity Securities held in the Portfolio.

The Fund’s distribution target is $0.0583 per Class A Unit per month ($0.70 per annum) or US$0.0583 per Class U Unit per month (US$0.70 per annum).

Cumulative Growth $10,000 Invested

September 30, 2017 (NAV pricing)

HHL series A
HHL series U

Downloads

Link to prospectus Why Invest

Link to prospectus Quarterly Summary

Link to prospectus Prospectus Eng | Fr

Link to prospectus Summary Documents  HHL EngFr

Link to prospectus Summary Documents  HHL.U Eng | Fr

Portfolio Management

Paul MacDonald Harvest Portfolios Group Inc.

PAUL MACDONALD, CFA

Chief Investment Officer

 

Portfolio Manager

JAMES LEARMONTH, CFA

Portfolio Manager

MIKE DRAGOSITS, CFA

Associate Portfolio Manager

Investor Suitability

Investors seeking a regular income through investment in the worlds leading healthcare companies.

Investors seeking to hold their investment for medium to long term.

 

 

Historical Prices

 

 

Historical Distributions

 

 

Portfolio Holdings

Healthcare Leaders Income ETF
as of September 30, 2017

Security % of Portfolio
AbbVie Inc. 5.6
Bristol-Myers Squibb Company 5.2
AstraZeneca PLC ADR 5.1
Celgene Corporation 5.0
Anthem, Inc. 5.0
Pfizer Inc. 5.0
Amgen Inc. 4.9
Eli Lilly and Company  4.8
Stryker Corporation 4.8
Merck & Co., Inc. 4.8
UnitedHealth Group Inc. 4.7
GlaxoSmithKline PLC ADR 4.7
Boston Scientific Corp. 4.7
Novartis AG ADR 4.7
Allergan PLC 4.6
Medtronic PLC 4.6
Johnson & Johnson 4.6
Gilead Sciences, Inc. 4.6
Zoetis Inc. Class A 4.5
Quest Diagnostic Inc 4.4
Cash and other assets and liabilities 4.4
Foreign Currency Schedule 0.0
Options (0.5)

Press Releases

Disclaimer

Healthcare Leaders Income ETF

The Fund originally commenced operations as a TSX listed closed-end fund on December 18, 2014 and converted into an exchange-traded fund on October 24, 2016.  Commissions, management fees and expenses all may be associated with investing in HARVEST Exchange Traded Funds. Please read the relevant prospectus before investing. The indicated rates of return are the historical annual compounded total returns including changes in unit value and reinvestment of all distributions and do not take into account income taxes payable by any securityholder that would have reduced returns. The funds are not guaranteed, their values change frequently and past performance may not be repeated. Distributions are paid to you in cash unless you request, pursuant to your participation in a distribution reinvestment plan, that they be reinvested into Class A or Class U units of the Fund. If the Fund earns less than the amounts distributed, the difference is a return of capital. Tax, investment and all other decisions should be made with guidance from a qualified professional.

*Source: Bloomberg.  Average statistics calculated based on portfolio weighted average. Dividend yield based on Bloomberg indicated 12 month yield of portfolios positions and does not represent the distribution yield paid to investors. P/E calculated based on Bloomberg consensus 12 month forward earnings estimates. Return on Equity (ROE) based on 5 year trailing average ROE. The above information is for illustrative purposes only, is estimated and unaudited.

Save
SaveSaveSaveSave